HLA-DR expression and soluble HLA-DR levels in septic patients after trauma

Annals of Surgery

Volumn 229, Issue 2, 1999, Pages 246-254

  Ditschkowski, Markus ^a   Kreuzfelder, Ernst ^a   Rebmann, Vera ^a   Ferencik, Stanislav ^a   Majetschak, Mathias ^a   Schmid, Ernst N ^a   Obertacke, Udo ^a   Hirche, Herbert ^a   Schade, Ulrich F ^a   Grosse Wilde, Hans ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; IMMUNE RESPONSE; INJURY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; SEPSIS; SEPTICEMIA; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; HLA-DR ANTIGENS; HUMANS; INJURY SEVERITY SCORE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; SEPSIS; T-LYMPHOCYTES; WOUNDS AND INJURIES;

EID: 0033505573     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199902000-00013     Document Type: Article

References (46)

1. Baker CC, Oppenheimer L, Stevens B, et al. Epidemiology of trauma deaths. Am J Surg 1980; 140:144-150.
2. Goris RJA, Draaisma J. Causes of death after blunt trauma. J Trauma 1982; 22:141-146.
3. Centers for Disease Control. Increase in national hospital discharge survey rates for septicemia - United States, 1979-1987. JAMA 1990; 263:937-938.
4. O'Mahony JB, Palder SB, Wood JJ, et al. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma 1984; 24:869-874.
5. Polk HC, George CD, Wellhausen SR, et al. A systematic study of host defense processes in badly injured patients. Ann Surg 1986; 204:282-297.
6. Faist E, Kupper TS, Baker CC, et al. Depression of cellular immunity after major injury. Arch Surg 1986; 121:1000-1005.
7. Nishijima MK, Takezawa J, Hosotsubo KK, et al. Serial changes in cellular immunity of septic patients with multiple organ-system failure. Crit Care Med 1986;14:87-91.
8. Christou NV, McLean APH, Meakins JL. Host defense in blunt trauma: interrelationships of kinetics of anergy and depressed neutrophil function, nutritional status, and sepsis. J Trauma 1980; 20:833-839.
9. Keane RM, Birmingham W, Shatney CM, et al. Prediction of sepsis in the multitraumatic patient by assays of lymphocyte responsiveness. Surg Gynecol Obstet 1983; 156:163-167.
10. O'Mahony JB, Wood JB, Rodrick ML, Mannick JA. Changes in T-lymphocyte subsets following injury. Ann Surg 1985; 202:580-586.
11. Faist E, Mewes A, Strasser T, et al. Alteration of monocyte function following major injury. Arch Surg 1988; 123:287-292.
12. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G. Depressed interferon-gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988; 123:1309-1312.
13. Faist E, Ertel W, Baker CC, Heberer G. Terminal B-cell maturation and immunoglobulin (Ig) synthesis in vitro in patients with major injury. J Trauma 1989; 29:2-9.
14. Baker SP, O'Neill B. The injury severity score: an update. J Trauma 1976; 16:882-886.
15. Greenspan L, McLellan BA, Greig H. Abbreviated injury scale and injury severity score: a scoring chart. J Trauma 1985; 25:60-64.
16. Chamion HR, Copes WS, Sacco WJ, et al. A new characterization of injury severity. J Trauma 1990; 30:539-549.
17. Hershman MJ, Cheadle WG, Kuftinec D, Polk Jr HC. An outcome predictive score for sepsis and death following injury. Injury 1988; 19:263-266.
18. Cheadle WG. The human leukocyte antigens and their relationship to infection. Am J Surg 1993; 165:75S-81S.
19. Hershman MJ, Cheadle WG, Wellhausen SR, et al. Monocyte HLA-DR expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77:204-207.
20. Cheadle WG, Hershman MJ, Wellhausen SR, Polk HC. HLA-DR expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 1991; 161:639-645.
21. Wakefield CH, Carey PD, Foulds S, et al. Changes in major histocompatibility complex II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993; 80:205-209.
22. Baehr RV, Volk HD, Reinke P, et al. An immune monitoring program for controlling immunosuppressive therapy. Transplant Proc 1989; 21:1189-1191.
23. Reinke P, Volk HD. Diagnostic and predictive value of an immune monitoring program for complications after kidney transplantation. Urol Int 1992; 49:69-75.
24. McDonald JC, Adamashvili I, Hayes JM, et al. Soluble HLA class II concentrations in normal individuals and transplant recipients. Comparison with soluble HLA class I concentrations. Transplantation 1994; 58:1268-1272.
25. Nicolle MW, Nag B, Sharma SD, Willcox N, et al. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest 1994; 93:1361-1369.
26. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8:411-426.
27. Huber BT, Hsu PN, Sutkowski N. Virus-encoded superantigens. Microbiol Rev 1996; 60:473-482.
28. Gutierrez-Ramos JC, Bluethmann H. Molecules and mechanisms operating in septic shock: lessons from knockout mice. Immunol Today 1997; 18:329-334.
29. Mottershead DG, Hsu PN, Urban RG, et al. Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules. Immunity 1995; 2:149-154.
30. American College of Chest Physicians/Society of Critical Care Medicine consensus conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
31. Westhoff U, Grosse-Wilde H. Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Vox Sang 1995; 68:73-76.
32. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39:225-235.
33. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41:119-134.
34. Döcke WD, Randow F, Syrbe U. et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nature Med 1997; 3:678-681.
35. Burgmann H, Winkler S, Locker GJ, et al. Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis. Clin Immunol Immunopathol 1996; 80:307-310.
36. Landmann R, Reber AM, Sansano S, Zimmerli W. Function of soluble CD14 in serum from patients with septic shock. J Infect Dis 1996; 173:661-668.
37. Chaudry IH, Ayala A. Effect of hemorrhage on specific immune responses. In Chaudry IH, Ayala A (eds). Immunological aspects of haemorrhage. Austin: RG Landes Co.; 1992:53-82.
38. Grosse-Wilde H, Blasczyk R, Westhoff U. Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations. Tissue Antigens 1992; 39:74-77.
39. Blasczyk R, Westhoff U, Grosse-Wilde H. Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet 1993; 341:789-790.
40. Lam L, Whitsett CF, McNicholl JM, et al. Immunologically active proteins in intravenous immunoglobulin. Lancet 1993; 342:678.
41. Dominioni L, Dionigi R, Zanello M, et al. Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater. Arch Surg 1991; 126:236-240.
42. Schedel I, Dreikhausen U, Nentwig B, et al. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit Care Med 1991; 19:1104-1113.
43. Singal DP, Qm X. Polymorphism in the upstream regulatory region and level of expression of HLA-DRB genes. Mol Immunol 1994; 31:1117-1120.
44. Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-1433.
45. Tobias PS, Ulevitch RJ. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 1993; 187: 227-232.
46. Heinzelmann M, Mercer-Jones M, Cheadle WG, Polk HC. CD14 expression in injured patients correlates with outcome. Ann Surg 1996; 224:91-96.